Gyon Technologies Capital Management, LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gyon Technologies Capital Management, LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$594,000
-68.0%
14,906
-66.1%
0.11%
-81.9%
Q2 2021$1,859,000
+541.0%
43,971
+617.4%
0.61%
+383.3%
Q1 2021$290,000
-60.6%
6,129
-49.2%
0.13%
-50.2%
Q4 2020$736,000
+38.6%
12,057
+6.1%
0.25%
-39.3%
Q3 2020$531,000
-11.9%
11,364
-4.4%
0.42%
-71.4%
Q2 2020$603,000
-9.9%
11,892
-14.6%
1.46%
+229.6%
Q4 2019$669,00013,9250.44%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ayer Capital Management, LP 416,666$7,153,00038.92%
Novo Holdings A/S 747,359$11,210,0002.78%
Bain Capital Public Equity Management, LLC 2,333,333$50,073,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 845,027$18,134,0000.84%
HealthCor Management, L.P. 732,200$15,713,0000.84%
RA Capital Management 300,000$6,438,0000.67%
Catalyst Capital Advisors LLC 30,666$658,0000.36%
CR Intrinsic Investors, LLC 119,237$2,559,0000.08%
Weiss Multi-Strategy Advisers LLC 284,130$6,098,0000.07%
SECTORAL ASSET MANAGEMENT INC 57,519$1,234,0000.06%
View complete list of PTC THERAPEUTICS INC shareholders